Format

Send to

Choose Destination
Clin Infect Dis. 1999 Jul;29(1):191-2.

Immune response to pneumococcal conjugate and polysaccharide vaccines in otitis-prone and otitis-free children.

Author information

1
Maxwell Finland Laboratory for Infectious Diseases, Boston Medical Center, and Boston University School of Public Health, Massachusetts 02118, USA. ebarnett@bu.edu

Abstract

We compared responses to pneumococcal conjugate and polysaccharide vaccines in 48 otitis-free and 64 otitis-prone children. Pre- and postimmunization concentrations of antibodies to pneumococcal serotypes 6B, 14, 19F, and 23F were measured by enzyme-linked immunosorbent assay. Postimmunization mean concentrations of antibodies to all four serotypes were significantly higher for children receiving conjugate vaccine than for those receiving polysaccharide vaccine; the difference in responses was primarily due to a better response to conjugate vaccine in the otitis-prone group. Significantly higher postimmunization concentrations of antibodies to all four serotypes and to one of the four serotypes were found in otitis-prone children and otitis-free children who received conjugate vaccine, respectively. Pneumococcal conjugate vaccine has the potential to reduce the incidence of disease due to vaccine serotypes, even among children with recurrent otitis media.

PMID:
10433584
DOI:
10.1086/520151
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Silverchair Information Systems
Loading ...
Support Center